HER-2/neu gene product in serum: An oncoprotein in the diagnosis and therapy of breast carcinomaSCHULZE, Guntram.Anticancer research. 2003, Vol 23, Num 2A, pp 1007-1010, issn 0250-7005, 4 p.Conference Paper

It's money that matters : the financial context of ethical decision-making in modern biomedicine = C'est l'argent qui compte : le contexte financier de la prise de décision éthique dans la biomédecine moderneHEDGECOE, Adam M.Sociology of health & illness (Print). 2006, Vol 28, Num 6, pp 768-784, issn 0141-9889, 17 p.Article

Development and validation of ELISA for Herceptin detection in human serumMAPLE, Laura; LATHROP, Rebecca; BOZICH, Shari et al.Journal of immunological methods. 2004, Vol 295, Num 1-2, pp 169-182, issn 0022-1759, 14 p.Article

Significant systemic therapeutic effects of high-LET immunoradiation by ²¹²Pb-trastuzumab against prostatic tumors of androgen-independent human prostate cancer in miceZONGQING TAN; PINGPING CHEN; SCHNEIDER, Nathan et al.International journal of oncology. 2012, Vol 40, Num 6, pp 1881-1888, issn 1019-6439, 8 p.Article

Annular erythema as a sign of recurrent breast cancerTAN, Eugene; KUPER-HOMMEL, Marion; RADEMAKER, Marius et al.Australasian journal of dermatology. 2010, Vol 51, Num 2, pp 135-138, issn 0004-8380, 4 p.Article

Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction CancerBANG, Yung-Jue.Journal of clinical gastroenterology. 2012, Vol 46, Num 8, pp 637-648, issn 0192-0790, 12 p.Article

Antitumor Effect of Paclitaxel-Loaded PEGylated Immunoliposomes Against Human Breast Cancer Cells : Theme Section on NanocarriersTAO YANG; CHOI, Min-Koo; CUI, Fu-De et al.Pharmaceutical research. 2007, Vol 24, Num 12, pp 2402-2411, issn 0724-8741, 10 p.Article

HER-2 and NF-κB as the targets for therapy-resistant breast cancerAHMED, Kazi M; NING CAO; JIAN JIAN LI et al.Anticancer research. 2006, Vol 26, Num 6B, pp 4235-4243, issn 0250-7005, 9 p.Article

Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatmentsBARROS, Fabrício F. T; POWE, Desmond G; ELLIS, Ian O et al.Histopathology. 2010, Vol 56, Num 5, pp 560-572, issn 0309-0167, 13 p.Article

Targeting the function of the HER2 oncogene in human cancer therapeuticsMOASSER, M. M.Oncogene (Basingstoke). 2007, Vol 26, Num 46, pp 6577-6592, issn 0950-9232, 16 p.Article

Angiosarcoma of the heart : Case report and review of the literatureBATZIOS, S; MICHALOPOULOS, A; KAKLAMANIS, L et al.Anticancer research. 2006, Vol 26, Num 6C, pp 4837-4842, issn 0250-7005, 6 p.Article

Herceptin-decorated Salinomycin-loaded nanoparticles for breast tumor targetingSEDA TIGLI AYDIN, R.Journal of biomedical materials research. Part A. 2013, Vol 101, Num 5, pp 1405-1415, issn 1549-3296, 11 p.Article

Adjuvant Trastuzumab in Breast Cancer: Experience from the University of FlorenceLIVI, L; BORGHESI, S; BIANCHI, S et al.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 2, pp 115-118, issn 1120-009X, 4 p.Article

The erbb2/JER2/neu receptor polymorphism Ile655Val and breast cancer riskCOX, David G; HANKINSON, Susan E; HUNTER, David J et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 7, pp 447-450, issn 1744-6872, 4 p.Article

Effects of Herceptin treatment on global gene expression patterns in HER2-amplified and nonamplified breast cancer cell linesKAURANIEMI, Päivikki; HAUTANIEMI, Sampsa; AUTIO, Reija et al.Oncogene (Basingstoke). 2004, Vol 23, Num 4, pp 1010-1013, issn 0950-9232, 4 p.Article

Plant-Produced Trastuzumab Inhibits the Growth of HER2 Positive Cancer CellsGROHS, Brittany M; YONGQING NIU; VELDHUIS, Linda J et al.Journal of agricultural and food chemistry (Print). 2010, Vol 58, Num 18, pp 10056-10063, issn 0021-8561, 8 p.Article

Oncogramme Responses of Breast Tumour Cells Treated with Herceptin Correlate with HER2/C-ERB B2 Pathological StatusGIRAUD, S; BOUNAIX MORAND DU PUCH, C; FERMEAUX, V et al.Anticancer research. 2012, Vol 32, Num 4, pp 1323-1325, issn 0250-7005, 3 p.Article

Trastuzumab therapy vs tetracycline controlled ERBB2 down regulation : influence on tumour development in an ERBB2-dependent mouse tumour modelHERMES, M; SCHORMANN, W; MÜLLER, G. A et al.British journal of cancer. 2008, Vol 98, Num 9, pp 1525-1532, issn 0007-0920, 8 p.Article

Rapamycin together with herceptin significantly increased anti-tumor efficacy compared to either alone in ErbB2 over expressing breast cancer cellsWANG, Lu-Hai; CHAN, Joseph L.-K; WEI LI et al.International journal of cancer. 2007, Vol 121, Num 1, pp 157-164, issn 0020-7136, 8 p.Article

ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell linesGINESTIER, C; ADELAÏDE, J; JACQUEMIER, J et al.Oncogene (Basingstoke). 2007, Vol 26, Num 50, pp 7163-7169, issn 0950-9232, 7 p.Article

Bladder carcinoma : understanding advanced and metastatic disease with potential molecular therapeutic targetsAHMED, Hashim Uddin; ARYA, Manit; PATEL, Hitendra R. H et al.Expert review of anticancer therapy. 2005, Vol 5, Num 6, pp 1011-1022, issn 1473-7140, 12 p.Article

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profilingSANTIN, A. D; ZHAN, F; SHAUGHNESSY, J. JR et al.British journal of cancer. 2004, Vol 90, Num 9, pp 1814-1824, issn 0007-0920, 11 p.Article

The effect of trastuzumab / docetaxel combination on breast cancer angiogenesis: Dichotomus effect predictable by the HIFIα/VEGF pre-treatment status?KOUKOURAKIS, Michael I; SIMOPOULOS, Constantinos; POLYCHRONIDIS, Alexandros et al.Anticancer research. 2003, Vol 23, Num 2C, pp 1673-1680, issn 0250-7005, 8 p.Article

Development and validation of cell-based ELISA for the quantification of trastuzumab in human plasmaJAMIESON, David; CRESTI, Nicola; VERRILL, Mark W et al.Journal of immunological methods. 2009, Vol 345, Num 1-2, pp 106-111, issn 0022-1759, 6 p.Article

Contact spotting of protein microarrays coupled with spike-in of normalizer protein permits time-resolved analysis of ERBB receptor signalingLÖBKE, Christian; LAIBLE, Mark; RAPPL, Claudia et al.Proteomics (Weinheim. Print). 2008, Vol 8, Num 8, pp 1586-1594, issn 1615-9853, 9 p.Article